“Worldwide market size of antimicrobial additives is expected to achieve more than USD 5 billion by 2030”, says Visiongain

15 October 2019
Chemicals

Visiongain’s new report the Antimicrobial Additives Market Report 2020-2030: Forecasts by Type (Inorganic, Organic), By End Use (Healthcare, Packaging, Food & Beverage, and Construction), By Application (Plastic, Paints & Coatings, Pulp & Paper), by region and analysis of leading companies operating in this industry.

According to a fresh study from Visiongain, the worldwide market size of antimicrobial additives is expected to achieve more than USD 5 billion by 2030. Expanding at a CAGR of 10 percent over the forecast period is expected. Market growth is driven by rising demand from various end-use industries, such as healthcare, packaging, food and beverage. In terms of revenue in 2020, these three end-use sectors accounted for a market share of more than 60%.

In the manufacture of medical devices such as sheaths, guidewires, access systems, guiding catheters, diagnostic catheters and thrombectomy instruments, antimicrobial additives are increasingly used to avoid microbial development. High incidence of illnesses combined with geriatric population, sedentary lifestyle, and unhealthy dietary habits may fuel additional demand for these appliances, which is expected to boost market growth in turn.

Due to their use in a wider spectrum of products and applications, including paints, coatings, textiles and polymers over organic additives, inorganic additives are anticipated to achieve important prominence over the coming years. They also have great capacities for protection. Inorganic additives such as copper salts, for example, provide antimicrobial protection in preservative and sterilized apps, with paints, coatings and polymers being the fundamental substrates or layers.

During the forecast period, Asia Pacific is projected to be the fastest growing region. It is anticipated that the rapidly increasing healthcare sector and the dominant packaging industry will boost the use of products in the region. The U.S. has been a significant consumer of antimicrobial additives on a global scale for many years. Some of the variables driving market growth in the healthcare sector are high demand for sophisticated medical facilities owing to the availability of reimbursement coverage and the active development of healthcare infrastructure.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

“The global market size of zeolite is estimated to exceed USD 34.64 Bn by 2020”, says Visiongain

The product’s non-toxicity and low cost enables them to be used to protect antimicrobials including yeasts, bacteria, and spores.

02 December 2019

Read

“The global market size of vegan cosmetics is estimated to exceed USD 14.5 Bn by 2020”, says Visiongain

The cosmetics industry is inherently highly competitive and demands top-performing products that reach the highest levels of creativity and performance.

02 December 2019

Read

“The global market size of U.S. pigment dispersion is estimated to exceed USD 6.74 Bn by 2020”, says Visiongain

Pigments are used on the basis of their application in food packaging in various plastics, paper and paperboard materials as well as inks.

02 December 2019

Read

“The global market size of rodenticides is estimated to exceed USD 914 Million by 2020”, says Visiongain

Growing population of rodents is a major factor behind increasing prevalence of communicable diseases such as Hantavirus infection, plague, and Lassa fever, which, in effect, affects the climate, wildlife, and humans.

02 December 2019

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever